Elvia Cowan insider trades

Open-market stock purchases and sales by Elvia Cowan, SVP, Finance & CAO at Vaxcyte, Inc, from SEC Form 4 filings since Mar 1, 2023.

Recent trades

DateStockTradeValue
Sep 8, 2026PCVX Vaxcyte, IncSold (not open market)$80.1K
Sep 2, 2026PCVX Vaxcyte, IncSold (not open market)$20.1K
Aug 31, 2026PCVX Vaxcyte, IncSold (not open market)$14.8K
Apr 7, 2026PCVX Vaxcyte, IncSold$180K
Apr 7, 2026PCVX Vaxcyte, IncBought (not open market)—
Mar 17, 2026PCVX Vaxcyte, IncSold$82.4K
Mar 17, 2026PCVX Vaxcyte, IncSold$22.8K
Mar 11, 2026PCVX Vaxcyte, IncBought (not open market)—
Mar 11, 2026PCVX Vaxcyte, IncSold$146K
Mar 9, 2026PCVX Vaxcyte, IncSold (not open market)$29.4K
Mar 2, 2026PCVX Vaxcyte, IncSold (not open market)$20.2K
Feb 28, 2026PCVX Vaxcyte, IncSold (not open market)$15.1K
Feb 26, 2026PCVX Vaxcyte, IncBought (not open market)—
Feb 26, 2026PCVX Vaxcyte, IncBought (not open market)—
Feb 26, 2026PCVX Vaxcyte, IncBought (not open market)—
Dec 23, 2025PCVX Vaxcyte, IncSold$235K
Dec 23, 2025PCVX Vaxcyte, IncSold$322K
Dec 23, 2025PCVX Vaxcyte, IncSold (not open market)—

Companies traded

  • PCVX Vaxcyte, Inc: 12 sales, last Sep 8, 2026

Get free alerts when Elvia Cowan files a new trade →